BARNES & NOBLE EDUCATION INC(NYSE:BNED) stock Fundamental Analysis

Fundamental Rating

BNED gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 120 industry peers in the Specialty Retail industry. Both the profitability and financial health of BNED have multiple concerns. BNED does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BNED has reported negative net income.

In the past year BNED has reported a negative cash flow from operations.

In the past 5 years BNED always reported negative net income.

In multiple years BNED reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -8.25%, BNED is not doing good in the industry: 76.07% of the companies in the same industry are doing better.

BNED has a Return On Equity of -42.36%. This is in the lower half of the industry: BNED underperforms 70.09% of its industry peers.

Looking at the Return On Invested Capital, with a value of 3.73%, BNED is in line with its industry, outperforming 50.43% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-8.25%
ROE	-42.36%
ROIC	3.73%

ROA(3y)-7.93%

ROA(5y)-8.13%

ROE(3y)-65.88%

ROE(5y)-50.9%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Operating Margin of BNED (1.60%) is comparable to the rest of the industry.

BNED's Operating Margin has declined in the last couple of years.

With a Gross Margin value of 22.77%, BNED is not doing good in the industry: 77.78% of the companies in the same industry are doing better.

BNED's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	1.6%
PM (TTM)	N/A
GM	22.77%

OM growth 3YN/A

OM growth 5Y-30.77%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y11.61%

GM growth 5Y-2.57%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BNED is destroying value.

BNED has less shares outstanding than it did 1 year ago.

BNED has less shares outstanding than it did 5 years ago.

The debt/assets ratio for BNED is higher compared to a year ago.

2.2 Solvency

BNED has an Altman-Z score of 1.03. This is a bad value and indicates that BNED is not financially healthy and even has some risk of bankruptcy.

BNED's Altman-Z score of 1.03 is on the low side compared to the rest of the industry. BNED is outperformed by 74.36% of its industry peers.

BNED has a Debt/Equity ratio of 0.87. This is a neutral value indicating BNED is somewhat dependend on debt financing.

BNED has a Debt to Equity ratio (0.87) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.87
Debt/FCF	N/A
Altman-Z	1.03

ROIC/WACC0.31

WACC12.08%

2.3 Liquidity

BNED has a Current Ratio of 1.31. This is a normal value and indicates that BNED is financially healthy and should not expect problems in meeting its short term obligations.

With a Current ratio value of 1.31, BNED perfoms like the industry average, outperforming 44.44% of the companies in the same industry.

BNED has a Quick Ratio of 1.31. This is a bad value and indicates that BNED is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 0.61, BNED is in the better half of the industry, outperforming 61.54% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.31
Quick Ratio	0.61

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BNED shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.81%, which is quite impressive.

The Revenue has been growing slightly by 1.38% in the past year.

The Revenue has been decreasing by -5.09% on average over the past years.

EPS 1Y (TTM)77.81%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-95.93%

Revenue 1Y (TTM)1.38%

Revenue growth 3Y3.67%

Revenue growth 5Y-5.09%

Sales Q2Q%-1.35%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y91.96%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-0.43%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BNED. In the last year negative earnings were reported.

Also next year BNED is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BNED indicates a somewhat cheap valuation: BNED is cheaper than 74.36% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	7.29

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for BNED!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BARNES & NOBLE EDUCATION INC

NYSE:BNED (2/21/2025, 8:04:00 PM)

After market: 10.2 0 (0%)

10.2

-0.4 (-3.77%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustrySpecialty Retail

Earnings (Last)12-09 2024-12-09/bmo

Earnings (Next)03-10 2025-03-10/bmo

Inst Owners65.08%

Inst Owner Change311.77%

Ins Owners6.02%

Ins Owner Change-2.56%

Market Cap308.14M

Analysts43.33

Price TargetN/A

Short Float %4.86%

Short Ratio0.98

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-2.93%

Min EPS beat(2)-96.94%

Max EPS beat(2)91.09%

EPS beat(4)2

Avg EPS beat(4)-449.24%

Min EPS beat(4)-1864.71%

Max EPS beat(4)91.09%

EPS beat(8)3

Avg EPS beat(8)-275.08%

EPS beat(12)3

Avg EPS beat(12)-218.03%

EPS beat(16)4

Avg EPS beat(16)-177.31%

Revenue beat(2)0

Avg Revenue beat(2)-4.46%

Min Revenue beat(2)-5.17%

Max Revenue beat(2)-3.75%

Revenue beat(4)1

Avg Revenue beat(4)-4.39%

Min Revenue beat(4)-8.85%

Max Revenue beat(4)0.22%

Revenue beat(8)3

Avg Revenue beat(8)-1.4%

Revenue beat(12)3

Avg Revenue beat(12)-2.89%

Revenue beat(16)5

Avg Revenue beat(16)-3.29%

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)-99.29%

EPS NQ rev (3m)-99.29%

EPS NY rev (1m)83.32%

EPS NY rev (3m)83.32%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)-2.66%

Revenue NY rev (3m)-2.66%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.2
P/FCF	N/A
P/OCF	N/A
P/B	1.5
P/tB	2.57
EV/EBITDA	7.29

EPS(TTM)-33.73

EYN/A

EPS(NY)-6.29

Fwd EYN/A

FCF(TTM)-2.09

FCFYN/A

OCF(TTM)-1.68

OCFYN/A

SpS51.58

BVpS6.78

TBVpS3.96

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-8.25%
ROE	-42.36%
ROCE	4.72%
ROIC	3.73%
ROICexc	3.81%
ROICexgc	4.56%
OM	1.6%
PM (TTM)	N/A
GM	22.77%
FCFM	N/A

ROA(3y)-7.93%

ROA(5y)-8.13%

ROE(3y)-65.88%

ROE(5y)-50.9%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5Y-34.2%

ROICexc growth 3YN/A

ROICexc growth 5Y-31.19%

OM growth 3YN/A

OM growth 5Y-30.77%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y11.61%

GM growth 5Y-2.57%

F-Score6

Asset Turnover1.48

Health

		Industry Rank	Sector Rank
Debt/Equity	0.87
Debt/FCF	N/A
Debt/EBITDA	2.66
Cap/Depr	29.73%
Cap/Sales	0.8%
Interest Coverage	1.2
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.31
Quick Ratio	0.61
Altman-Z	1.03

F-Score6

WACC12.08%

ROIC/WACC0.31

Cap/Depr(3y)57.74%

Cap/Depr(5y)57.66%

Cap/Sales(3y)1.59%

Cap/Sales(5y)1.74%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)77.81%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-95.93%

EPS Next Y91.96%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)1.38%

Revenue growth 3Y3.67%

Revenue growth 5Y-5.09%

Sales Q2Q%-1.35%

Revenue Next Year-0.43%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y193.04%

EBIT growth 3YN/A

EBIT growth 5Y-34.29%

EBIT Next Year440.37%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-35.21%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-269.38%

OCF growth 3YN/A

OCF growth 5YN/A

BARNES & NOBLE EDUCATION INC (BNED) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens